Amalgamated Bank’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$16K Hold
1,783
﹤0.01% 2214
2025
Q1
$14K Hold
1,783
﹤0.01% 2230
2024
Q4
$10K Hold
1,783
﹤0.01% 2444
2024
Q3
$13K Hold
1,783
﹤0.01% 2335
2024
Q2
$19K Hold
1,783
﹤0.01% 2145
2024
Q1
$33K Sell
1,783
-5,521
-76% -$102K ﹤0.01% 1979
2023
Q4
$158K Sell
7,304
-530
-7% -$11.5K ﹤0.01% 1866
2023
Q3
$161K Hold
7,834
﹤0.01% 1851
2023
Q2
$368K Buy
7,834
+2,377
+44% +$112K ﹤0.01% 1578
2023
Q1
$229K Sell
5,457
-1,507
-22% -$63.2K ﹤0.01% 1746
2022
Q4
$266K Buy
6,964
+235
+3% +$8.98K ﹤0.01% 1746
2022
Q3
$264K Buy
6,729
+155
+2% +$6.08K ﹤0.01% 1739
2022
Q2
$212K Sell
6,574
-2,404
-27% -$77.5K ﹤0.01% 1855
2022
Q1
$297K Sell
8,978
-311
-3% -$10.3K ﹤0.01% 1776
2021
Q4
$395K Sell
9,289
-7,765
-46% -$330K ﹤0.01% 1691
2021
Q3
$756K Sell
17,054
-489
-3% -$21.7K 0.01% 1388
2021
Q2
$997K Buy
17,543
+11,323
+182% +$644K 0.01% 1291
2021
Q1
$466K Sell
6,220
-439
-7% -$32.9K 0.02% 1025
2020
Q4
$576K Sell
6,659
-17
-0.3% -$1.47K 0.02% 891
2020
Q3
$408K Sell
6,676
-2
-0% -$122 0.02% 954
2020
Q2
$278K Sell
6,678
-6,645
-50% -$277K 0.01% 1154
2020
Q1
$383K Sell
13,323
-228
-2% -$6.55K 0.01% 1029
2019
Q4
$978K Buy
13,551
+921
+7% +$66.5K 0.02% 811
2019
Q3
$1.77M Buy
12,630
+1,487
+13% +$209K 0.04% 499
2019
Q2
$2.04M Buy
11,143
+99
+0.9% +$18.1K 0.05% 383
2019
Q1
$1.76M Buy
11,044
+876
+9% +$139K 0.04% 457
2018
Q4
$974K Buy
10,168
+3,930
+63% +$376K 0.03% 656
2018
Q3
$881K Sell
6,238
-4,383
-41% -$619K 0.02% 740
2018
Q2
$1.66M Buy
10,621
+4,998
+89% +$783K 0.04% 480
2018
Q1
$906K Buy
5,623
+476
+9% +$76.7K 0.02% 738
2017
Q4
$848K Buy
5,147
+744
+17% +$123K 0.02% 775
2017
Q3
$274K Buy
4,403
+25
+0.6% +$1.56K 0.01% 1262
2017
Q2
$349K Buy
4,378
+686
+19% +$54.7K 0.01% 1111
2017
Q1
$262K Buy
+3,692
New +$262K 0.01% 1224